Webinar

Global outlook for eCTD 4.0 adoption: Successes and challenges

Although the main International Council for Harmonisation (ICH) eCTD v4.0 standard has been available since 2015, implementation at regulatory agencies to date has been slow. Recently, however, the pace has quickened. Watch an insightful webinar on demand for an informative update from our eCTD expert Karl-Heinz Loebel on the accelerating adoption of eCTD 4.0, and key challenges still facing industry. In addition, he will provide pragmatic guidance for companies seeking to implement the updated standard and provide an outlook on future extensions to the standard.

Key learnings

  • Findings and lessons learned from the second phase of the EMA’s eCTD 4.0 EU technical pilot, and expectations for the coming months.
  • Current state of eCTD 4.0 submissions to the FDA, exploring the synergies between US and EU applications.
  • Important considerations for companies looking to adopt eCTD 4.0, including how it fits into your overall workflow of creating submissions, handling of the controlled vocabularies, keywords, and other eCTD 4.0 features.
  • How forward compatibility works with the lifecycle of an existing eCTD dossier.
  • Potential applications of eCTD 4.0 capabilities to the submission of structured product data in the future.
abstract globe

Access the recording

Pardot Form

Connect with our team

Our team of leading value experts is dedicated to transforming evidence, policy insights, and market intelligence into effective global market access strategies. Let us help you navigate today’s complex healthcare landscape with confidence. Reach out to discover how we can support your goals.

Related resources

Article

Q&A for innovators: Navigating the complex regulatory world of ATMPs/CGTs

Article

The drivers and benefits of the UK’s clinical trials regulation amendment

Article

Workshop sheds light on important statistical advances for the biopharma industry

Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.

Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.